| Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medicationsHORIZON-HLTH-2027-01-CARE-02 | Horizon Europe · Cluster 1 Health | | Open |
| Development of novel small molecule antiviral therapeutics for pathogens with epidemic potentialHORIZON-HLTH-2027-01-DISEASE-05 | Horizon Europe · Cluster 1 Health | | Open |
| Development of monoclonal antibodies to prevent and treat infections from FlavivirusesHORIZON-HLTH-2027-01-DISEASE-06 | Horizon Europe · Cluster 1 Health | | Open |
| Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga virusesHORIZON-HLTH-2027-01-DISEASE-07 | Horizon Europe · Cluster 1 Health | | Open |
| Development of innovative antimicrobials against pathogens resistant to antimicrobialsHORIZON-HLTH-2027-01-DISEASE-08 | Horizon Europe · Cluster 1 Health | | Open |
| Prevention and management of chronic non-communicable diseases in children and young people (GACD)HORIZON-HLTH-2027-01-DISEASE-10 | Horizon Europe · Cluster 1 Health | | Open |
| Integrating climate-related exposures into the human exposome and characterising its changes in response to climate changeHORIZON-HLTH-2027-01-ENVHLTH-02 | Horizon Europe · Cluster 1 Health | | Open |
| Tools and technologies to support health adaptation to climate changeHORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03 | Horizon Europe · Cluster 1 Health | | Open |
| Development of cell-free protein synthesis platforms for discovery and/or production of biologicalsHORIZON-HLTH-2027-01-IND-01 | Horizon Europe · Cluster 1 Health | | Open |
| Addressing disabilities through the life course to support independent living and inclusionHORIZON-HLTH-2027-01-STAYHLTH-01 | Horizon Europe · Cluster 1 Health | | Open |
| Innovative healthcare interventions for non-communicable diseasesHORIZON-HLTH-2027-02-DISEASE-01-two-stage | Horizon Europe · Cluster 1 Health | | Open |
| Clinical trials for advancing innovative interventions for neurodegenerative diseasesHORIZON-HLTH-2027-02-DISEASE-14-two-stage | Horizon Europe · Cluster 1 Health | | Open |
| Portable and versatile Point-of-care diagnosticsHORIZON-HLTH-2027-02-IND-02-two-stage | Horizon Europe · Cluster 1 Health | | Open |
| Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseasesHORIZON-HLTH-2027-02-TOOL-01-two-stage | Horizon Europe · Cluster 1 Health | | Open |
| European Partnership for Pandemic Preparedness (Phase 2)HORIZON-HLTH-2026-03-DISEASE-13 | Horizon Europe · Cluster 1 Health | | Forthcoming |
| Advancing bio-printing of living cells for regenerative medicineHORIZON-HLTH-2027-03-TOOL-02 | Horizon Europe · Cluster 1 Health | | Forthcoming |
| Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosisHORIZON-HLTH-2027-03-TOOL-04 | Horizon Europe · Cluster 1 Health | | Forthcoming |
| Towards the next generation of frontier Artificial Intelligence models for healthcareHORIZON-HLTH-2027-03-TOOL-08 | Horizon Europe · Cluster 1 Health | | Forthcoming |